Sanofi Reports Positive Phase 3 Results for Nexvia...
Category : Clinical Trial Update 1 July 2026Phase 3 Study Meets Primary and Secondary Endpoints Sanofi has announced positive topline results...
Clinical Trial Update
NeuroSense Reports Positive Phase 2b Results for P...
Category : Clinical Trial Update 30 June 2026PrimeC Achieves Primary Goal in Phase 2b ALS Trial NeuroSense Therapeutics has announ...
Otsuka Reports Positive Phase 3b Results for Centa...
Category : Clinical Trial Update 29 June 2026Otsuka Announces Positive Topline Results from Phase 3b Trial Otsuka Pharmaceutical Co., Ltd. and...
BridgeBio Publishes Positive Phase 3 Results for O...
Category : Clinical Trial Update 29 June 2026BridgeBio Shares Positive Phase 3 Data in NEJM BridgeBio Pharma has announced that positive resul...
Ascletis Receives FDA Clearance to Begin Phase I S...
Category : Clinical Trial Update 25 June 2026Ascletis Advances New Obesity Treatment Candidate Into Clinical Development Ascletis Pharma has...
Latest Newsletter Post
-
Sanofi Reports Positive Phase 3 Res..
1 July 2026
-
Artivion Receives US FDA Approval f..
1 July 2026
-
NeuroSense Reports Positive Phase 2..
30 June 2026
-
Alembic Pharmaceuticals Receives US..
30 June 2026
-
BridgeBio Publishes Positive Phase..
29 June 2026
